Accedi

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.

One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall exposure in the body over time. The trapezoidal method is commonly employed to calculate this area.

Bioavailability, denoted as F, is another important factor in the noncompartmental approach. It refers to the fraction of an administered dose that reaches the systemic circulation unchanged. Bioavailability can be determined by analyzing drug concentration data, providing insights into the drug's absorption and systemic availability.

The total volume of distribution, represented as Vss, is a parameter that reflects the extent of drug distribution throughout the body. It is calculated by multiplying the drug's clearance by the mean residence time, which refers to the average time a drug molecule spends in the body.

However, calculating the mean residence time using the noncompartmental approach does have one limitation. It can only be readily calculated after a single intravenous (IV) dose. This restriction sets the noncompartmental approach apart from the compartmental approach, which allows more flexibility in estimating pharmacokinetic parameters.

In summary, the noncompartmental approach in pharmacokinetics utilizes clearance, bioavailability, and total volume of distribution to assess the behavior of drugs in the body. It involves calculating the total clearance by dividing the drug dose by the area under the concentration-time curve, determining bioavailability using drug concentration data, and estimating the total volume of distribution by multiplying clearance and mean residence time. However, the noncompartmental approach is limited in calculating mean residence time, as it requires a single dose of IV administration.

Tags

Noncompartmental AnalysisPharmacokineticsDrug ClearanceBioavailabilityTotal Volume Of DistributionArea Under The CurveTrapezoidal MethodSystemic CirculationMean Residence TimeIntravenous DoseDrug Absorption

Dal capitolo 7:

article

Now Playing

7.29 : Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

Pharmacokinetic Models

34 Visualizzazioni

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

53 Visualizzazioni

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

51 Visualizzazioni

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

105 Visualizzazioni

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

95 Visualizzazioni

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

35 Visualizzazioni

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

109 Visualizzazioni

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

38 Visualizzazioni

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

146 Visualizzazioni

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

212 Visualizzazioni

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

63 Visualizzazioni

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

53 Visualizzazioni

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

74 Visualizzazioni

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

202 Visualizzazioni

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

140 Visualizzazioni

See More

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati